Lipidomics Revealed Idiopathic Pulmonary Fibrosis-Induced Hepatic Lipid Disorders Corrected with Treatment of Baicalin in a Murine Model

Changfeng Hu, Yiqi Wang, Yongsheng Fan, Haichang Li, Chunyan Wang, Jida Zhang, Shuijuan Zhang, Xianlin Han, Chengping Wen

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease. The current standard treatment with glucocorticoids (GCs) leads to many adverse effects, and its effectiveness is questionable. Thus, it is critical and urgent to find new drug(s) for treatment of IPF. Baicalin (BAI) is an attractive candidate for this purpose. Herein, utilizing shotgun lipidomics, we revealed that IPF could lead to a lipid disorder of the liver in an animal model induced by bleomycin and confirmed through histopathological studies of the lung. Lipidomics further demonstrated that this disorder could virtually be corrected after treatment with BAI, but not with dexamethasone (DEX) (a commonly used GC for treatment of IPF). In contrast, the treatment with DEX did not improve IPF but led to tremendous alterations in hepatic lipidomes and accumulation of fat in the liver, which was very different from the lipid disorder induced by IPF. The underpinning mechanisms of the IPF-resultant lipid disorder and DEX-induced lipotoxicity as revealed by shotgun lipidomics were extensively discussed. Taken together, the current study showed that IPF could lead to hepatic lipid disorder, which can be treated with BAI, and demonstrated that lipidomics could be a powerful tool for drug screening.

Original languageEnglish (US)
Pages (from-to)711-722
Number of pages12
JournalAAPS Journal
Volume17
Issue number3
DOIs
StatePublished - May 1 2015
Externally publishedYes

Fingerprint

Idiopathic Pulmonary Fibrosis
Lipids
Liver
Dexamethasone
Firearms
Glucocorticoids
Preclinical Drug Evaluations
baicalin
Bleomycin
Lung Diseases
Animal Models
Fats
Lung

Keywords

  • baicalin
  • hepatic lipidome
  • idiopathic pulmonary fibrosis
  • multidimensional mass spectrometry
  • shotgun lipidomics

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Lipidomics Revealed Idiopathic Pulmonary Fibrosis-Induced Hepatic Lipid Disorders Corrected with Treatment of Baicalin in a Murine Model. / Hu, Changfeng; Wang, Yiqi; Fan, Yongsheng; Li, Haichang; Wang, Chunyan; Zhang, Jida; Zhang, Shuijuan; Han, Xianlin; Wen, Chengping.

In: AAPS Journal, Vol. 17, No. 3, 01.05.2015, p. 711-722.

Research output: Contribution to journalArticle

Hu, Changfeng ; Wang, Yiqi ; Fan, Yongsheng ; Li, Haichang ; Wang, Chunyan ; Zhang, Jida ; Zhang, Shuijuan ; Han, Xianlin ; Wen, Chengping. / Lipidomics Revealed Idiopathic Pulmonary Fibrosis-Induced Hepatic Lipid Disorders Corrected with Treatment of Baicalin in a Murine Model. In: AAPS Journal. 2015 ; Vol. 17, No. 3. pp. 711-722.
@article{d06bd95acc2c44d4a6368eda8a32f6d3,
title = "Lipidomics Revealed Idiopathic Pulmonary Fibrosis-Induced Hepatic Lipid Disorders Corrected with Treatment of Baicalin in a Murine Model",
abstract = "Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease. The current standard treatment with glucocorticoids (GCs) leads to many adverse effects, and its effectiveness is questionable. Thus, it is critical and urgent to find new drug(s) for treatment of IPF. Baicalin (BAI) is an attractive candidate for this purpose. Herein, utilizing shotgun lipidomics, we revealed that IPF could lead to a lipid disorder of the liver in an animal model induced by bleomycin and confirmed through histopathological studies of the lung. Lipidomics further demonstrated that this disorder could virtually be corrected after treatment with BAI, but not with dexamethasone (DEX) (a commonly used GC for treatment of IPF). In contrast, the treatment with DEX did not improve IPF but led to tremendous alterations in hepatic lipidomes and accumulation of fat in the liver, which was very different from the lipid disorder induced by IPF. The underpinning mechanisms of the IPF-resultant lipid disorder and DEX-induced lipotoxicity as revealed by shotgun lipidomics were extensively discussed. Taken together, the current study showed that IPF could lead to hepatic lipid disorder, which can be treated with BAI, and demonstrated that lipidomics could be a powerful tool for drug screening.",
keywords = "baicalin, hepatic lipidome, idiopathic pulmonary fibrosis, multidimensional mass spectrometry, shotgun lipidomics",
author = "Changfeng Hu and Yiqi Wang and Yongsheng Fan and Haichang Li and Chunyan Wang and Jida Zhang and Shuijuan Zhang and Xianlin Han and Chengping Wen",
year = "2015",
month = "5",
day = "1",
doi = "10.1208/s12248-014-9714-4",
language = "English (US)",
volume = "17",
pages = "711--722",
journal = "AAPS Journal",
issn = "1550-7416",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Lipidomics Revealed Idiopathic Pulmonary Fibrosis-Induced Hepatic Lipid Disorders Corrected with Treatment of Baicalin in a Murine Model

AU - Hu, Changfeng

AU - Wang, Yiqi

AU - Fan, Yongsheng

AU - Li, Haichang

AU - Wang, Chunyan

AU - Zhang, Jida

AU - Zhang, Shuijuan

AU - Han, Xianlin

AU - Wen, Chengping

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease. The current standard treatment with glucocorticoids (GCs) leads to many adverse effects, and its effectiveness is questionable. Thus, it is critical and urgent to find new drug(s) for treatment of IPF. Baicalin (BAI) is an attractive candidate for this purpose. Herein, utilizing shotgun lipidomics, we revealed that IPF could lead to a lipid disorder of the liver in an animal model induced by bleomycin and confirmed through histopathological studies of the lung. Lipidomics further demonstrated that this disorder could virtually be corrected after treatment with BAI, but not with dexamethasone (DEX) (a commonly used GC for treatment of IPF). In contrast, the treatment with DEX did not improve IPF but led to tremendous alterations in hepatic lipidomes and accumulation of fat in the liver, which was very different from the lipid disorder induced by IPF. The underpinning mechanisms of the IPF-resultant lipid disorder and DEX-induced lipotoxicity as revealed by shotgun lipidomics were extensively discussed. Taken together, the current study showed that IPF could lead to hepatic lipid disorder, which can be treated with BAI, and demonstrated that lipidomics could be a powerful tool for drug screening.

AB - Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease. The current standard treatment with glucocorticoids (GCs) leads to many adverse effects, and its effectiveness is questionable. Thus, it is critical and urgent to find new drug(s) for treatment of IPF. Baicalin (BAI) is an attractive candidate for this purpose. Herein, utilizing shotgun lipidomics, we revealed that IPF could lead to a lipid disorder of the liver in an animal model induced by bleomycin and confirmed through histopathological studies of the lung. Lipidomics further demonstrated that this disorder could virtually be corrected after treatment with BAI, but not with dexamethasone (DEX) (a commonly used GC for treatment of IPF). In contrast, the treatment with DEX did not improve IPF but led to tremendous alterations in hepatic lipidomes and accumulation of fat in the liver, which was very different from the lipid disorder induced by IPF. The underpinning mechanisms of the IPF-resultant lipid disorder and DEX-induced lipotoxicity as revealed by shotgun lipidomics were extensively discussed. Taken together, the current study showed that IPF could lead to hepatic lipid disorder, which can be treated with BAI, and demonstrated that lipidomics could be a powerful tool for drug screening.

KW - baicalin

KW - hepatic lipidome

KW - idiopathic pulmonary fibrosis

KW - multidimensional mass spectrometry

KW - shotgun lipidomics

UR - http://www.scopus.com/inward/record.url?scp=84939980310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939980310&partnerID=8YFLogxK

U2 - 10.1208/s12248-014-9714-4

DO - 10.1208/s12248-014-9714-4

M3 - Article

VL - 17

SP - 711

EP - 722

JO - AAPS Journal

JF - AAPS Journal

SN - 1550-7416

IS - 3

ER -